Amsbio (Oxford, UK) reports that its iMatrix-511 recombinant laminin product has been cited in a recent paper from researchers at the Stanford University School of Medicine (CA, USA) as a pivotal tool for stem cell culture and blastoid formation. This groundbreaking study describes how human blastoid models (stem-cell derived blastocyst-like structures) were used to investigate how human-specific LTR5Hs elements regulate early embryonic development. It provides new insights into epiblast differentiation and early embryogenesis. iMatrix 511 is a highly purified and refined version of the human recombinant laminin-511 E8 fragment expressed by CHO-S cells. Widely regarded as a gold standard for stem cell culture, iMatrix-511 is an innovative cell culture matrix that permits ES/iPS cells to be maintained in feeder-free culture conditions. Immediately available from stock– iMatrix-511 also enables the passaging of single cells and is proven to provide greater adhesion than full-length Laminin, Vitronectin or Matrigel. iMatrix-511 can also be used together with Amsbio’s StemFit cell culture media and CELLBANKER cryopreservation series as part of an expanded Stem Cell Synergy solution for ES/iPS cell cultures. For further information about iMatrix-511 recombinant laminin products please visit https://www.amsbio.com/imatrix-recombinant-laminin-511/ or contact Amsbio on +31-72-8080244 / +44-1235-828200 / +1-617-945-5033 / info@amsbio.com. About Amsbio Now part of the Europa Biosite group of companies, AMS Biotechnology (Amsbio) is recognized as a leading transatlantic company contributing to the acceleration of discovery through the provision of cutting-edge life science technology, products and services for R&D in the medical, nutrition, cosmetics and energy industries. Amsbio has in-depth expertise in…
